- €3.84bn
- €4.67bn
- €1.20bn
Italy - Factors to watch on May 20
Diasorin jumps as earnings fall less than expected, backs outlook
Italy - Factors to watch on May 11
Italy's DiaSorin posts 28% Q1 profit decline on weak flu season
Brief: Diasorin Q1 Adj. EBITDA EUR 90 Mln
Italy - Factors to watch on May 8
Italy - Factors to watch on April 29
DiaSorin falls as Qiagen cuts outlook on QuantiFERON weakness
DiaSorin slides on expectation of 'another year with no margin growth'
Italy - Factors to watch on March 23
Italy's DiaSorin cautions on supply chain, logistics risks as it sets 2026 targets
Brief: Diasorin FY Adjusted EBITDA EUR 394 Mln
Italy - Factors to watch on March 20
Brief: Diasorin Submits LIAISON NES Group A Strep Molecular Test To The U.S. FDA For 510(K) Clearance And CLIA Waiver
Brief: Diasorin Receives Approval For HDV Laboratory Test In The U.S.
Italy - Factors to watch on January 26
Brief: Diasorin Appoints Alberto Donati As Group CFO
Live Markets: Is Medtech ready to turn the corner?
DiaSorin rises as FDA okays new molecular diagnostic platform